血清25-羟维生素D与糖尿病前期及糖尿病患者心血管结局和全因死亡率的关联:英国生物银行前瞻性队列研究结果
基于英国生物银行前瞻性队列,纳入67,789例糖尿病前期和24,311例糖尿病患者,基线无心血管疾病和癌症。经过10-14年随访,血清25(OH)D水平与心血管结局及全因死亡率呈显著非线性负相关。与最低水平组(<25 nmol/L)相比,最高水平组(≥75 nmol/L)的糖尿病前期患者心血管事件、冠心病、心力衰竭、卒中、心血管死亡和全因死亡风险均显著降低;糖尿病患者除卒中外的上述结局也观察到类似关联。
要点
- 糖尿病前期者25(OH)D≥75 nmol/L组较<25 nmol/L组心血管事件HR 0.78、全因死亡HR 0.66。
- 糖尿病者25(OH)D≥75 nmol/L组较<25 nmol/L组心血管死亡HR 0.43,但卒中关联无显著。
- 血清25(OH)D与心血管结局和全因死亡率呈显著非线性负相关(非线性P<0.05)。
核心结论
- 在糖尿病前期和糖尿病成人中,较高的血清25(OH)D水平与较低的心血管结局和全因死亡率风险显著相关,且呈非线性关系。
- 研究结果强调监测和纠正维生素D缺乏对预防该人群心血管疾病和死亡的重要性。
研究设计与样本
- 英国生物银行前瞻性队列研究,纳入基线无心血管疾病和癌症的67,789例糖尿病前期个体和24,311例糖尿病个体。
- 基线测量血清25(OH)D浓度,采用Cox比例风险模型计算10-14年随访期间心血管结局和死亡的风险比(HR)及95%CI,并进行多变量调整。
主要发现
- 多变量调整后,糖尿病前期和糖尿病患者中较高的血清25(OH)D水平与较低的心血管结局和全因死亡率风险显著非线性相关(所有非线性P<0.05)。
- 糖尿病前期患者中,25(OH)D最高组(≥75 nmol/L)相比最低组(<25 nmol/L):心血管事件HR 0.78(95%CI 0.71-0.86),冠心病HR 0.79(95%CI 0.71-0.89),心力衰竭HR 0.66(95%CI 0.54-0.81),卒中HR 0.75(95%CI 0.61-0.93),心血管死亡HR 0.43(95%CI 0.32-0.59),全因死亡HR 0.66(95%CI 0.58-0.75)。
- 糖尿病患者中,25(OH)D最高组(≥75 nmol/L)相比最低组(<25 nmol/L)也观察到心血管事件、冠心病、心力衰竭、心血管死亡和全因死亡的类似关联,但卒中除外。
关键数值与推荐
- 25(OH)D最低类别为<25 nmol/L,最高类别为≥75 nmol/L。
- 糖尿病前期患者最高vs最低类别:心血管事件HR 0.78(95%CI 0.71-0.86),冠心病HR 0.79(95%CI 0.71-0.89),心力衰竭HR 0.66(95%CI 0.54-0.81),卒中HR 0.75(95%CI 0.61-0.93),心血管死亡HR 0.43(95%CI 0.32-0.59),全因死亡HR 0.66(95%CI 0.58-0.75)。
- 糖尿病患者最高vs最低类别:心血管事件、冠心病、心力衰竭、心血管死亡和全因死亡存在类似关联,卒中除外。
临床怎么用
- 原文未据此给出具体临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine the associations of circulating 25-hydroxyvitamin D (25[OH]D) concentrations with cardiovascular disease (CVD) and all-cause mortality in individuals with prediabetes and diabetes from the large population-based UK Biobank cohort study. RESEARCH DESIGN AND METHODS: A total of 67,789 individuals diagnosed with prediabetes and 24,311 with diabetes who had no CVD or cancer at baseline were included in the current study. Serum 25(OH)D concentrations were measured at baseline. Cox proportional hazard models were used to calculate hazard ratios (HRs) and 95% CIs for cardiovascular outcomes and mortality after 10-14 years. RESULTS: After multivariable adjustment, higher serum 25(OH)D levels were significantly and nonlinearly associated with lower risk of cardiovascular outcomes and all-cause mortality among participants with prediabetes and diabetes (all P nonlinearity < 0.05). Compared with those in the lowest category of 25(OH)D levels (<25 nmol/L), participants with prediabetes in the highest category of 25(OH)D levels (≥75 nmol/L) had a significant association with lower risk of cardiovascular events (HR 0.78; 95% CI 0.71-0.86), coronary heart disease (CHD) (HR 0.79; 95% CI 0.71-0.89), heart failure (HR 0.66; 95% CI 0.54-0.81), stroke (HR 0.75; 95% CI 0.61-0.93), CVD mortality (HR 0.43; 95% CI 0.32-0.59), and all-cause mortality (HR 0.66; 95% CI 0.58-0.75). Likewise, these associations with cardiovascular events, CHD, heart failure, CVD mortality, and all-cause mortality were observed among participants with diabetes, except for stroke. CONCLUSIONS: These findings highlight the importance of monitoring and correcting vitamin D deficiency in the prevention of CVD and mortality among adults with prediabetes and diabetes.
引用
- Zhang P, Guo D, Xu B, et al. Association of Serum 25-Hydroxyvitamin D With Cardiovascular Outcomes and All-Cause Mortality in Individuals With Prediabetes and Diabetes: Results From the UK Biobank Prospective Cohort Study. Diabetes Care. 2022. PMID: 35226734. doi:10.2337/dc21-2193
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。